Side-by-side comparison of AI visibility scores, market position, and capabilities
Global payment technology company serving regulated and high-risk verticals including iGaming, financial services, and digital goods with specialized compliance and acquiring capabilities.
Nuvei is a Montreal-based global payment technology company founded in 2003 and publicly listed on Nasdaq and the TSX, providing payment processing, acquiring, and risk management to merchants in regulated and high-complexity verticals where standard payment providers decline to operate. The company has deep expertise in iGaming and online sports betting — a highly regulated industry with complex age verification, responsible gaming, and jurisdictional licensing requirements — as well as financial services, cryptocurrency exchanges, and nutraceuticals. Nuvei holds payment processing licenses in over 40 countries and supports 600+ local and alternative payment methods, enabling clients to operate in markets with specific regulatory and payment method requirements. The platform's risk management layer includes real-time fraud scoring, chargebacks management, and regulatory compliance tools built specifically for merchants operating in legally complex environments. Nuvei acquired SafeCharge in 2019, SimplexCC in 2021, and Paya Holdings in 2023 to expand its technology capabilities and vertical coverage. The company processes over $200B in annual payment volume. Nuvei competes with Everi, Global Payments, and Paysafe in regulated verticals, and with Stripe and Adyen in broader digital commerce, differentiating on its willingness to serve industries with elevated compliance requirements.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.